Studies have shown that increased expression of CCL2 is a hallmark of NASH, promoting the infiltration of monocyte-derived macrophages through CCL2-mediated chemotaxis. This evidence concerns the gene CCL2 and metabolic dysfunction-associated steatohepatitis.